Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 151

Results For "event"

1891 News Found

Indoco Remedies receives USFDA approval for Lacosamide tablets
Drug Approval | March 22, 2022

Indoco Remedies receives USFDA approval for Lacosamide tablets

According to IQVIA sales data for the period ending January 2022, Vimpat tablets market achieved annual sales of approx. US $ 1.7 billion


Hester Biosciences foray into pet care industry
News | March 22, 2022

Hester Biosciences foray into pet care industry

Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products


Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health
News | March 22, 2022

Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health

Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now


MFine brings Blood Pressure and Glucose Monitoring on smartphones
Public Health | March 22, 2022

MFine brings Blood Pressure and Glucose Monitoring on smartphones

Enables millions of Indians to monitor their vitals without the need of any additional device


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
News | March 21, 2022

Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India

Sputnik Light is the first component of Sputnik V


AstraZeneca launches global R&D post-doctoral challenge
News | March 18, 2022

AstraZeneca launches global R&D post-doctoral challenge

Successful proposals will secure fully funded postdoctoral research positions


Merck discontinues KEYLYNK-101 trial to treat prostate cancer
Biotech | March 18, 2022

Merck discontinues KEYLYNK-101 trial to treat prostate cancer

At the interim analysis, the combination of Keytruda and Lynparza did not demonstrate a benefit in overall survival (OS), one of the study’s dual primary endpoints, compared to the control arm of either abiraterone acetate or enzalutamide


Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)
News | March 18, 2022

Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)

The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years